Mr Naga Venkatesh Jayanthi MD, FRCS
Bupa - Consultant Surgeon
Consultant Laparoscopic & Robotic Surgeon Cancer Lead, Essex Upper GI, Honorary Senior Lecturer
Mr Jayanthi graduated from the prestigious Bangalore Medical College & Research Institute in India. After undertaking research at University of Oxford he completed specialist surgical training from All Wales Higher Surgical Training programme. Following this, Mr Jayanthi did fellowships at world-renowned centres of excellence. He spent a year as a Senior Laparoscopic Fellow at ICENI, Colchester (Centre for advanced laparoscopic surgery), another year as a Senior Registrar at St James’ University Hospital, Leeds (leading centre for Gastro-Oesophageal cancer) and completed much coveted Ethicon Bariatric Fellowship at Musgrove Park Hospital, Taunton (International Centre of Excellence).
Mr Jayanthi is a Consultant Surgeon specialising in treatment of Benign & Malignant Upper GI pathology and Bariatric Surgery. His practice includes Laparoscopic, Thoracoscopic and Robotic surgery. Mr Jayanthi is the Cancer Lead for Essex Upper GI, Regional Centre for Oesophago-gastric Surgery.
Minimal Invasive Oesophagectomy – where are we going?
Despite huge number of technological advances and various other surgical specialties, fully adapting minimally invasive surgeries, Minimal Invasive Oesophagectomy seems to be contentious and divisive in the world of Oesophageal surgery. In this lecture, I would like to explore the issues stalling progress of this technique. And discuss issues in ‘curability’ of
EVEN MORE SEMINARS
Richard Edwards BSc MBBS FRCS FRCS MD Circle Bath Hospital
Michael Schreiber Brain Tumor Foundation, Chairman
Brain Tumors - Innovation, support and advocacy
Professor A. Graham Pockley multimmune GmbH / Nottingham Trent University
A new era of cancer therapeutics?
Mylaine Riobe MD, FABOIM, FACOG Riobe Institute of Integrative Medicine
Cancer is not random! Evolving mechanisms for cancer causation and prevention
Dr Christy Goldsmith Action Radiotherapy
Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)